• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305-19
Device Problems Material Integrity Problem (2978); Insufficient Information (3190)
Patient Problems Host-Tissue Reaction (1297); Stroke/CVA (1770); Endocarditis (1834); Myocardial Infarction (1969); Thrombus (2101); Transient Ischemic Attack (2109); Blood Loss (2597); Thromboembolism (2654)
Event Date 08/19/2009
Event Type  Injury  
Manufacturer Narrative
Citation: riess et al."clinical results of the medtronic mosaic porcine bioprosthesis up to 13 years." eur j cardiothorac surg.2010 jan; 37 (1): 145-53.Doi: 10.1016/j.Ejcts.2009.04.073.Epub 2009 aug 19.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding 13-year clinical results of the medtronic mosaic porcine bioprosthesis.All data were collected from a single center between february 1994 and october 1999.The study population included 255 patients (predominantly male, mean age 67 years) who underwent aortic valve replacement and 47 patients (predominantly female, mean age 67 years) who underwent mitral valve replacement with a medtronic mosaic bioprosthetic valve (no serial numbers provided).Among aortic valve replacement patients two notable early deaths occurred within 30 days of surgery or before discharge.The first death was on postoperative day 3 due to hypertrophic obstructive cardiomyopathy with left ventricular outlet obstruction.The second death was on postoperative day 13 due to acute pericardial tamponade after aortic dissection and perforation.Based on the available information medtronic product may have been associated with these two early deaths.Among aortic valve replacement patients, adverse events included: structural valve dysfunction, pannus, thromboembolism (permanent neurological event, transient neurological attack, peripheral embolic event), acute myocardial infarction, valvular thrombosis, endocarditis, major bleeding, valve-related reoperation.Based on the available information medtronic product was associated with the adverse event(s).Among mitral valve replacement patients, adverse events included: structural valve dysfunction, thromboembolism (permanent neurological event, peripheral embolic event), endocarditis, major bleeding, and valve-related reoperation.Based on the available information medtronic product was associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8502250
MDR Text Key141576813
Report Number2025587-2019-01182
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 04/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number305-19
Device Catalogue Number305-19
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age67 YR
-
-